Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Andrea R. Genazzani, Tiziana Fidecicchi, Domenico Arduini, Andrea Giannini & Tommaso Simoncini. (2023) Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice. Gynecological Endocrinology 39:1.
Read now
Read now
Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari & Fabio Facchinetti. (2022) Contraception During Perimenopause: Practical Guidance. International Journal of Women's Health 14, pages 913-929.
Read now
Read now
Giovanni Grandi, Fabio Facchinetti & Johannes Bitzer. (2022) Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism. The European Journal of Contraception & Reproductive Health Care 27:2, pages 83-84.
Read now
Read now
Suzanne Reed, Carol Koro, Julia DiBello, Kerstin Becker, Anja Bauerfeind, Christian Franke & Klaas Heinemann. (2021) Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism. The European Journal of Contraception & Reproductive Health Care 26:6, pages 439-446.
Read now
Read now
Giovanni Grandi, Maria Chiara Del Savio & Fabio Facchinetti. (2021) The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Review of Clinical Pharmacology 14:2, pages 211-224.
Read now
Read now
Maria Chiara Del Savio, Riccardo De Fata, Fabio Facchinetti & Giovanni Grandi. (2020) Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception. Expert Review of Clinical Pharmacology 13:7, pages 685-694.
Read now
Read now
Giovanni Grandi, Maria Chiara Del Savio, Agnaldo Lopes da Silva-Filho & Fabio Facchinetti. (2020) Estetrol (E4): the new estrogenic component of combined oral contraceptives. Expert Review of Clinical Pharmacology 13:4, pages 327-330.
Read now
Read now
Jeffrey T. Jensen, Johannes Bitzer, Rossella E. Nappi, Christiane Ahlers, Ralf Bannemerschult & Susanne Parke. (2020) Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under. The European Journal of Contraception & Reproductive Health Care 25:2, pages 98-105.
Read now
Read now
Giovanni Grandi, Fabio Barra, Simone Ferrero & Fabio Facchinetti. (2019) Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Review of Endocrinology & Metabolism 14:3, pages 153-155.
Read now
Read now
Giovanni Grandi, Fabio Facchinetti & Johannes Bitzer. (2017) Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle?. The European Journal of Contraception & Reproductive Health Care 22:4, pages 245-246.
Read now
Read now
Angelo Cagnacci. (2017) Hormonal contraception: venous and arterial disease. The European Journal of Contraception & Reproductive Health Care 22:3, pages 191-199.
Read now
Read now
Carlo Bastianelli, Manuela Farris, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism. Expert Review of Clinical Pharmacology 10:3, pages 315-326.
Read now
Read now
Articles from other publishers (23)
Ömer Özcan, Wendy P.J. den Elzen, Jacquelien J. Hillebrand, Martin den Heijer, Laura L. van Loendersloot, Johan Fischer, Henrike Hamer, Robert de Jonge & Annemieke C. Heijboer. (2024) The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review. Clinical Chemistry and Laboratory Medicine (CCLM) 62:1, pages 18-40.
Crossref
Crossref
Giuseppe Seghieri, Elisa Gualdani, Flavia Franconi, Ilaria Campesi, Graziano Di Cianni & Paolo Francesconi. (2023) Pregestational exposure to hormonal combined contraceptives and risk of gestational diabetes: an observational retrospective population study. Acta Diabetologica.
Crossref
Crossref
Giovanni Grandi, Maria C. Del Savio, Alice Tassi & Fabio Facchinetti. (2023) Postpartum contraception: A matter of guidelines. International Journal of Gynecology & Obstetrics.
Crossref
Crossref
Anna Helena Mazurek, Łukasz Szeleszczuk, Kostas Bethanis, Elias Christoforides, Marta Katarzyna Dudek, Monika Zielińska-Pisklak & Dariusz Maciej Pisklak. (2023) 17-β-Estradiol—β-Cyclodextrin Complex as Solid: Synthesis, Structural and Physicochemical Characterization. Molecules 28:9, pages 3747.
Crossref
Crossref
Veronika I. Komedina, Svetlana V. Yureneva & Sergey Yu. Kuznetsov. (2023) Effect of combined oral contraceptives with estrogen identical to natural estrogen on the metabolic profile and body composition in females during the menopausal transition. Gynecology 24:6, pages 487-493.
Crossref
Crossref
M H Kangasniemi, R K Arffman, S Joenväärä, A Haverinen, K Luiro, T Tohmola, R Renkonen, O Heikinheimo, J S Tapanainen & T T Piltonen. (2023) Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial. Human Reproduction 38:1, pages 89-102.
Crossref
Crossref
L.I. Maltseva & Yu.V. Garifullova. (2023) Long-term contraception with combined hormonal drugs until menopause. Benefits and risks. Problemy reproduktsii 29:5, pages 102.
Crossref
Crossref
Pedro-Antonio Regidor, Anna Mueller & Manuela Mayr. (2023) Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen. Women's Health 19, pages 174550572211473.
Crossref
Crossref
Ilaria Campesi & Flavia Franconi. 2023. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
869
886
.
Camila G. Neves, Adriana L. Montiel, Fausto E. B. Junior, Guilherme C. Paveglio & Willyam R. P. Barros. (2022) Application of a Screen-Printed Carbon Electrode Modified with Printex 6L and Deep Eutectic Solvent for Detection and Quantification of 17β-estradiol. Journal of The Electrochemical Society 169:5, pages 057501.
Crossref
Crossref
Decio Armanini, Marco Boscaro, Luciana Bordin & Chiara Sabbadin. (2022) Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism. International Journal of Molecular Sciences 23:8, pages 4110.
Crossref
Crossref
Costantino DI CARLO, Massimo ABBONDANZA, Antonella AGNELLO, Giovanni CAVALLI, Lorenza DRIUL, Massimo PETRIGLIA, Andrea TINELLI, Alessandra TIRELLI, Anna TUSEI & Giovanni GRANDI. (2021) Current and future hormonal contraception in Italy: results from an Italian consensus expert meeting. Minerva Obstetrics and Gynecology 73:5.
Crossref
Crossref
Gerda Venter, Carien L. van der Berg, Francois H. van der Westhuizen & Elardus Erasmus. (2021) Health Status Is Affected, and Phase I/II Biotransformation Activity Altered in Young Women Using Oral Contraceptives Containing Drospirenone/Ethinyl Estradiol. International Journal of Environmental Research and Public Health 18:20, pages 10607.
Crossref
Crossref
Jovana Mihajlovic, Michael Leutner, Bela Hausmann, Gudrun Kohl, Jasmin Schwarz, Hannah Röver, Nina Stimakovits, Peter Wolf, Katharina Maruszczak, Magdalena Bastian, Alexandra Kautzky‐Willer & David Berry. (2021) Combined hormonal contraceptives are associated with minor changes in composition and diversity in gut microbiota of healthy women. Environmental Microbiology 23:6, pages 3037-3047.
Crossref
Crossref
Christine Klipping, Ingrid Duijkers, Marie Mawet, Catherine Maillard, Adriana Bastidas, Maud Jost & Jean-Michel Foidart. (2021) Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception 103:4, pages 213-221.
Crossref
Crossref
R.I. Gabidullina, E.I. Galimyanova & R.R. Salakhova. (2021) Effects of combined oral contraceptives on female sexuality: continuing the conversation. Problemy reproduktsii 27:5, pages 54.
Crossref
Crossref
Andrea Cignarella, Roberto Mioni, Chiara Sabbadin, Francesca Dassie, Matteo Parolin, Roberto Vettor, Mattia Barbot & Carla Scaroni. (2020) Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS. International Journal of Molecular Sciences 21:24, pages 9554.
Crossref
Crossref
Jonathan Douxfils, Laure Morimont & Céline Bouvy. (2020) Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk. Seminars in Thrombosis and Hemostasis 46:08, pages 872-886.
Crossref
Crossref
Marika H Kangasniemi, Annina Haverinen, Kaisu Luiro, J Kalervo Hiltunen, Elina K Komsi, Riikka K Arffman, Oskari Heikinheimo, Juha S Tapanainen & Terhi T Piltonen. (2020) Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial. The Journal of Clinical Endocrinology & Metabolism 105:7, pages e2483-e2490.
Crossref
Crossref
Łukasz Szeleszczuk, Dariusz Maciej Pisklak, Monika Zielińska-Pisklak & Ewa Jurczak. (2019) A new polymorph of 17-β-estradiol and the application of different analytical techniques (ssNMR, PXRD, DSC, and FTIR) for its study. Journal of Molecular Structure 1183, pages 274-280.
Crossref
Crossref
G. В. Dikke. (2019) Therapeutic tactics in abnormal uterine bleeding without anatomical substrate. Medical Council:21, pages 168-172.
Crossref
Crossref
Łukasz Szeleszczuk, Ewa Jurczak, Monika Zielińska-Pisklak, Jakub Harwacki & Dariusz Maciej Pisklak. (2018) Comparison of the analytical methods (solid state NMR, FT-IR, PXRD) in the analysis of the solid drug forms with low concentration of an active ingredient – 17-β-estradiol case. Journal of Pharmaceutical and Biomedical Analysis 149, pages 160-165.
Crossref
Crossref
G. B. Dikke. (2018) Protective activity and safety of multiphase combined oral contraceptive based on natural estrogens in women of advanced age. Problemy reproduktsii 24:3, pages 27.
Crossref
Crossref